India Glycols Limited
All news and filings related to India Glycols Limited.
View all news & filings- High impact
India Glycols Approves Audited FY26 Results; Declares Interim Dividend
India Glycols Limited reported audited standalone results for the quarter and year ended March 31, 2026. Profit After Tax for the quarter was ₹110.28 crore, up from ₹50.35 crore last year. Full-year Profit After Tax was ₹282.33 crore, up from ₹180.38 crore. The company declared an interim dividend of ₹7.50 per share.
Read the summary - Low impact
India Glycols Announces Q4 & FY26 Earnings Conference Call on May 18
India Glycols Limited will host an Earnings Conference Call on Monday, May 18, 2026, at 16:00 Hrs. IST. The call will focus on discussing the Q4 and Full Year FY26 financial results. Key management personnel will be present.
Read the summary - Low impact
India Glycols Schedules Q4 & FY26 Earnings Conference Call for May 18
India Glycols Limited will host an Earnings Conference Call on May 18, 2026, at 16:00 IST to discuss Q4 and Full Year FY26 financial results. Key management personnel will participate in the call.
Read the summary - Medium impact
India Glycols Board Meeting on May 14, 2026, to approve Q4 FY26 results
India Glycols will hold a Board Meeting on May 14, 2026, to approve audited standalone and consolidated financial results for Q4 FY26. The trading window remains closed until May 16, 2026.
Read the summary - Low impact
India Glycols Limited announces hearing for scheme of arrangement on May 21, 2026
India Glycols Limited has announced a hearing for a Company Scheme Petition on May 21, 2026. The hearing is related to a Scheme of Arrangement involving India Glycols Limited, Ennature Bio Pharma Limited, and IGL Spirits Limited. The National Company Law Tribunal (NCLT) has scheduled this hearing.
Read the summary - Low impact
India Glycols Publishes Newspaper Ad for Share Transfer Window
India Glycols Limited announced a special window for transfer and dematerialization of physical shares, open from Feb 5, 2026, to Feb 4, 2027. This follows a SEBI circular to facilitate investors with pre-April 2019 shares.
Read the summary - Low impact
India Glycols Limited: Appellate Authority Reduces Penalty to ₹10,000
India Glycols Limited's penalty of Rs. 7,20,570 has been set aside by the Appellate Authority. A new penalty of Rs. 10,000 has been imposed due to a clerical error in an E-way bill. The company will not appeal further due to litigation costs.
Read the summary - Medium impact
India Glycols: NCLT Admits Second Motion Petition for Scheme of Arrangement
NCLT has admitted India Glycols Limited's Second Motion Petition for its Scheme of Arrangement. The order directs newspaper publications and notices to authorities, who have 30 days to respond. Further proceedings are scheduled for May 21, 2026. The scheme is subject to regulatory approvals.
Read the summary - Low impact
India Glycols Files Certificate Under SEBI Regulations for Q4 FY26
India Glycols Limited filed a certificate under SEBI regulations for the quarter ended March 31, 2026. The company's RTA confirmed proper processing of dematerialized securities, including listing and cancellation of original certificates.
Read the summary - Low impact
India Glycols: Trading Window Closed from April 1, 2026, for FY26 Audited Results
India Glycols Limited will close its trading window from April 1, 2026. The window will reopen 48 hours after the declaration of audited financial results for the financial year ending March 31, 2026.
Read the summary - Medium impact
India Glycols: Unsecured Creditors Approve Scheme of Arrangement on March 24, 2026
India Glycols Limited's Unsecured Creditors approved a Scheme of Arrangement on March 24, 2026. The meeting, held via Video Conference, saw 27 creditors participate. The resolution concerning the arrangement among India Glycols, Ennature Bio Pharma, and IGL Spirits was passed with the required majority.
Read the summary - Medium impact
India Glycols Shareholders Approve Scheme of Arrangement
India Glycols Limited shareholders approved a Scheme of Arrangement involving Ennature Bio Pharma Limited and IGL Spirits Limited during a meeting on March 24, 2026. The resolution, requiring a special majority, passed with 100% of polled votes in favour. The NCLT had ordered the meeting.
Read the summary - Medium impact
India Glycols Declares Interim Dividend of ₹7.50 per Share
India Glycols Limited has declared an interim dividend of ₹7.50 per equity share (150%) for FY 2025-26. The record date is March 23, 2026. Shareholders must submit tax documents by March 23, 2026. Dividends will be paid electronically.
Read the summary - Medium impact
India Glycols declares ₹7.50 interim dividend; Record date March 23
India Glycols declared an interim dividend of ₹7.50 per equity share for FY 2025-26. The record date for the dividend is March 23, 2026. Shareholders must submit TDS-related documents by the same date. Dividend payments will be made electronically within 30 days of declaration.
Read the summary - Medium impact
India Glycols Declares Interim Dividend of ₹7.5 Per Share for FY26
India Glycols declared an interim dividend of ₹7.5 per share for FY25-26. The record date for this dividend is March 23, 2026. Payment will be made within 30 days of declaration to eligible shareholders.
Read the summary - Medium impact
India Glycols Declares Interim Dividend of ₹7.5 Per Share
India Glycols Limited declared an interim dividend of ₹7.5 per equity share (150%) for FY 2025-26. The record date is set for March 23, 2026. Payment will be made within 30 days of declaration.
Read the summary - Medium impact
India Glycols JV Declares Interim Dividend; IGL Receives ₹36 Cr
India Glycols Limited's joint venture, Clariant IGL Specialty Chemical Private Limited, declared an interim dividend of ₹36,000 per share. IGL received ₹36 crore gross dividend from this declaration on 17th March 2026.
Read the summary - Low impact
India Glycols Partially Wins Customs Appeal, Duty Demand Reduced
India Glycols received a partial win in its customs appeal. The Appellate Authority upheld a Rs. 33.43 crore duty demand with interest and a Rs. 41 crore penalty, but set aside the Rs. 191.76 crore redemption fine. The company plans a second appeal, expecting no material impact.
Read the summary - Medium impact
India Glycols Ratings on Watch with Developing Implications by CARE
India Glycols' credit ratings for long-term and short-term facilities are on Rating Watch with Developing Implications by CARE Ratings. This follows a proposed demerger of undertakings into separate entities. The company raised ₹467 crore via preferential issue in Q3FY26 for debt reduction. CARE expects adjusted overall gearing to decline to ~0.7x by FY26-end.
Read the summary - Medium impact
India Glycols Board Meeting on Mar 17 to Consider Interim Dividend
India Glycols board meeting scheduled for March 17, 2026, to consider interim dividend for FY25-26. Trading window closed from March 11 to March 19, 2026.
Read the summary - Medium impact
India Glycols Announces Shareholder and Creditor Meetings for Scheme of Arrangement
India Glycols Limited will hold meetings for Equity Shareholders and Unsecured Creditors on March 24, 2026, via Video Conference. These meetings are for a Scheme of Arrangement involving demergers. Remote e-voting is open from March 20-23, 2026. Cut-off dates for voting entitlement are November 15, 2025, and March 17, 2026.
Read the summary - Medium impact
India Glycols: Unsecured Creditors Meeting on March 24, 2026, for Scheme of Arrangement
India Glycols Limited will hold a meeting for Unsecured Creditors on March 24, 2026, to approve a Scheme of Arrangement. This involves demerging its Spirits, Biofuel, and Biopharma businesses into separate entities. Remote e-voting is open from March 20-23, 2026. The cut-off date for creditors is November 15, 2025.
Read the summary - Medium impact
India Glycols Ltd. Shareholders Meeting on March 24, 2026, for Scheme of Arrangement
India Glycols Limited will hold an Equity Shareholders meeting on March 24, 2026, via Video Conference. The meeting will consider and approve a Scheme of Arrangement involving the demerger of entities. Remote e-voting is open from March 20-23, 2026. The cut-off date for voting eligibility is March 17, 2026.
Read the summary - Low impact
India Glycols Announces Special Window for Physical Share Transfer & Dematerialization
India Glycols has opened a special window from February 5, 2026, to February 4, 2027, for transferring and dematerializing physical shares. This facility is for shares purchased before April 19, 2018, where transfer requests were previously rejected or not lodged. Shareholders should submit documents to MCS Share Transfer Agent Limited.
Read the summary - High impact
India Glycols Q3 FY26: Record Revenue & EBITDA, Debt Reduction
India Glycols reported record Q3 and 9M FY26 revenue and EBITDA. Q3 revenue rose 13% and EBITDA 36.1%. 9M revenue increased 11.4%, EBITDA 28.9%. Potable Spirits revenue grew 17% in 9M to ₹1,025 crore. The company achieved significant debt reduction of ₹582 crore and focused on high-margin chemicals and biofuels.
Read the summary - Low impact
India Glycols Q3 FY26 Earnings Conference Call Audio Recording Available
India Glycols Limited has released the audio recording of its Q3 & 9MFY26 earnings conference call held on February 12, 2026. The recording is accessible on the company's website via a provided link.
Read the summary - High impact
India Glycols Q3FY26: Revenue Up 13%, EBITDA Surges 36%, Debt Reduced by ₹582 Cr
India Glycols Limited reported a 13.0% YoY increase in Q3 FY26 net revenue to ₹1,102 Cr and a 36.1% surge in EBITDA to ₹176 Cr. For 9MFY26, revenue grew 11.4% to ₹3,235 Cr, with EBITDA up 28.9% to ₹487 Cr. The company achieved a ₹582 Cr debt reduction, including ₹467 Cr from preferential allotment. A demerger into separate entities is planned.
Read the summary - Low impact
India Glycols: Monitoring Agency Report for Q3FY26 on Preferential Issue Proceeds
India Glycols Limited's Monitoring Agency Report for Q3FY25 shows no deviation in the utilization of ₹466.99 crore raised via preferential issue. Funds were used for working capital and general corporate purposes, including term loan repayments, as per the offer document. All objects were completed by Q3FY26.
Read the summary - Medium impact
India Glycols Appoints Rakesh Kumar Srivastava as Head Operations
India Glycols Limited has appointed Shri Rakesh Kumar Srivastava as Head Operations (Dehradun). He joins as Senior Management Personnel, effective February 10, 2026. Srivastava has over 29 years of experience in the chemical and pharmaceutical sectors.
Read the summary - Medium impact
India Glycols Q3FY26 Results: Profit Up 18.8% YoY to ₹67.57 Crore
India Glycols reported a consolidated profit after tax of ₹67.57 crore for Q3FY26, up 18.8% YoY. Nine-month profit stood at ₹205.88 crore, up 23.4% YoY. Revenue for Q3FY26 was ₹2,551.10 crore. The Board approved the results on February 10, 2026.
Read the summary - Low impact
India Glycols Announces Q3 & 9MFY26 Earnings Conference Call on Feb 12
India Glycols Limited will host an Earnings Conference Call on Thursday, February 12, 2026, at 16:00 IST. The call will focus on the company's financial results for Q3 and 9M FY26. Key management, including the CEO and CFO, will participate.
Read the summary - Low impact
India Glycols Announces Q3 & 9MFY26 Earnings Conference Call on Feb 12, 2026
India Glycols Limited will host its Q3 & 9MFY26 Earnings Conference Call on Thursday, February 12, 2026, at 16:00 IST. The call will feature the CEO, CFO, and other key management personnel to discuss financial results.
Read the summary - Medium impact
India Glycols Board Meeting on Feb 10, 2026 to Approve Q3 FY26 Results
India Glycols board meeting scheduled for February 10, 2026, to approve unaudited financial results for Q3 FY26 and nine months ended December 31, 2025. Trading window remains closed until February 12, 2026.
Read the summary - Medium impact
India Glycols: NCLT Approves Scheme of Arrangement for Demerger
India Glycols Limited's Scheme of Arrangement for demerging its Bio Pharma and Spirits/Biofuel undertakings has been allowed by NCLT. Meetings for shareholders and unsecured creditors are scheduled for March 9, 2026. The appointed date for the demerger is April 1, 2026.
Read the summary - Low impact
India Glycols Limited Files SEBI Compliance Certificate for Q3 FY26
India Glycols Limited filed a certificate under SEBI regulations for the quarter ended December 31, 2025. The RTA confirmed dematerialization processing, including listing and cancellation of certificates, with depository substitution. This is a routine compliance filing.
Read the summary - Medium impact
India Glycols Ordered to Pay ₹32.95 Lakhs Customs Duty, Penalty
India Glycols Limited received an order confirming a customs duty demand of ₹32.95 lakhs and an equal penalty of ₹32.95 lakhs for its Ennature Bio-Pharma division. The issue relates to customs classification of imported goods between June 2020 and September 2024. The company plans to appeal and anticipates no material financial impact.
Read the summary - Low impact
India Glycols: Trading Window Closed Jan 1, 2026, for Q3 FY26 Results
India Glycols Limited's trading window for securities will be closed from January 1, 2026. The closure is in effect until 48 hours after the declaration of financial results for the quarter and nine months ending December 31, 2025.
Read the summary - Low impact
India Glycols Receives Favorable Order in Input Tax Credit Dispute
India Glycols received a favorable order from the Commissioner, CGST (Appeals), Noida, setting aside a demand for ₹1.92 crore related to disallowed Transitional Input Tax Credit.
Read the summary - Low impact
India Glycols Announces Special Window for Physical Share Transfer
India Glycols announces a special window for re-lodgement of physical share transfer requests from July 7, 2025, to January 6, 2026, as per SEBI guidelines. Re-lodged shares will be issued in demat mode.
Read the summary - Medium impact
India Glycols Allots Equity Shares on Preferential Basis
India Glycols successfully allots 51,03,765 equity shares on preferential basis, raising ₹466.99 crore to reduce debt by March 31, 2026. Scheme of Arrangement's appointed date is April 1, 2026.
Read the summary - Medium impact
India Glycols Allots Equity Shares via Preferential Allotment
India Glycols allots 51,03,765 equity shares at ₹915 per share, totaling ₹466.99 crore, to promoters and non-promoters. KHL ceases to be the holding company.
Read the summary - Medium impact
India Glycols Q2 & H1 FY26 Earnings Call Transcript
India Glycols Limited released the transcript of its Q2 & H1 FY26 earnings conference call, reporting revenue and profit growth across various segments, including biofuels and potable spirits.
Read the summary - Medium impact
India Glycols Receives Observation Letters for Scheme of Arrangement
India Glycols received observation letters from NSE & BSE for its Scheme of Arrangement with Ennature Biopharma & IGL Spirits, pending further regulatory and shareholder approvals.
Read the summary - Low impact
Audio Recording of Q2 & H1FY26 Earnings Conference Call
Audio recording of India Glycols Limited's Q2 & H1FY26 earnings conference call held on November 18, 2025, is available on the company's website.
Read the summary - Medium impact
India Glycols Investor Presentation for Q2 & H1FY26
India Glycols announces Q2 & H1FY26 results with revenue and profit growth. Restructuring is proposed through demerger of business into separate entities.
Read the summary - Medium impact
India Glycols Limited Approves Unaudited Financial Results for Quarter Ended Sep 2025
India Glycols Limited approved unaudited financial results for the quarter ended September 30, 2025, along with updates on the Composite Scheme of Arrangement, stock split, and preferential allotment.
Read the summary - High impact
India Glycols EGM approves preferential issue of equity shares with overwhelming majority
India Glycols' EGM on 12th November 2025 approved the preferential issue of equity shares with overwhelming majority. Voting results disclosed, showing strong shareholder support for capital raise.
Read the summary - Low impact
India Glycols Limited announces Q2 & H1FY26 Earnings Conference Call
India Glycols Limited will hold an earnings conference call on November 18, 2025, at 16:00 Hrs (IST) to discuss the financial results for Q2 & H1 FY26. Key executives will participate.
Read the summary - Low impact
India Glycols to host Q2 & H1 FY26 Earnings Conference Call on November 18, 2025
India Glycols Limited will host an earnings conference call on November 18, 2025, to discuss Q2 & H1 FY26 financial results with key management participants.
Read the summary - Medium impact
India Glycols to hold Board Meeting on Nov 14 to approve Q2 & H1 FY26 financial results
India Glycols will hold a Board Meeting on November 14, 2025, to approve Q2 and H1 FY26 unaudited financial results. The trading window remains closed until November 16, 2025.
Read the summary
Model portfolios
Filings are the raw material. These are what SEBI-registered experts build from them.
- Stocks
Bharat Rising
Built around India's own shifts: capex, household savings, energy and consumption.
Moderate-Aggressive25 holdings3+ yearsView portfolio - Stocks
All-Terrain
One equity portfolio instead of three: large, mid and small cap in a single book.
Moderate-Aggressive34 holdings3+ yearsView portfolio - Stocks
Core Compounders
Companies that have already been through a downturn and came out still growing.
Moderate20 holdings3+ yearsView portfolio - Stocks
Udaan
Fast-growing, less-covered companies still early in their runway.
Aggressive29 holdings5+ yearsView portfolio